Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images

NCT06399159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-05-22

No results posted yet for this study

Summary

Rising thyroid carcinoma rates, with papillary thyroid carcinoma (PTC) as the main type (85-90% of cases), often show early cervical lymph node spread. This increases the risk of PTC patients for recurrence and death. A new study's multimodal model fuses preoperative US and cytology images to better predict lymph node metastasis, aiming to improve treatment plans, reduce unnecessary surgeries, and enhance patient outcomes.

Conditions

  • Papillary Thyroid Carcinoma
  • Lymph Node Metastasis

Interventions

PROCEDURE

Thyroidectomy and lymph node dissection

All surgical specimens of thyroidectomy and lymph node dissection were subjected to paraffin-embedded histopathological examination, and postoperative were categorized as with cervical lymph node metastasis and without cervical lymph node metastasis.

Sponsors & Collaborators

  • Nanchong Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Xiachuan Qin, MD · Nanchong Central Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-03-01
Completion
2024-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06399159 on ClinicalTrials.gov